Exclusivity Period of Biologics Remains a Hurdle in Trans-Pacific Partnership Talks
By EsqSocial Corporation 27/08/15
The latest round of talks over the Trans-Pacific Partnership (TPP), a proposed Pacific Rim free-trade agreement, has ended with disagreement on a number of key issues, including the non-patent exclusivity period for biologic medications. In late...
By: Patterson Belknap Webb & Tyler LLP